A detailed history of Frontier Wealth Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Frontier Wealth Management LLC holds 3,574 shares of EW stock, worth $330,130. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,574
Previous 3,574 -0.0%
Holding current value
$330,130
Previous $432,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $4,325 - $6,413
-50 Reduced 1.4%
3,524 $335,000
Q4 2021

Feb 04, 2022

SELL
$106.37 - $130.68 $10,637 - $13,068
-100 Reduced 2.72%
3,574 $463,000
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $26,550 - $31,669
-258 Reduced 6.56%
3,674 $416,000
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $7,377 - $9,218
88 Added 2.29%
3,932 $407,000
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $25,649 - $29,558
-326 Reduced 7.82%
3,844 $322,000
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $7,169 - $9,123
-100 Reduced 2.34%
4,170 $380,000
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $13,438 - $17,488
-200 Reduced 4.47%
4,270 $341,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $171,469 - $229,311
2,980 Added 200.0%
4,470 $309,000
Q1 2020

May 08, 2020

BUY
$52.41 - $81.0 $78,090 - $120,690
1,490 New
1,490 $281,000
Q4 2019

Feb 13, 2020

SELL
$71.7 - $82.09 $128,343 - $146,941
-1,790 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$61.55 - $75.43 $3,077 - $3,771
-50 Reduced 2.72%
1,790 $394,000
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $28,734 - $38,430
-600 Reduced 24.59%
1,840 $352,000
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $37,169 - $43,329
-1,100 Reduced 31.07%
2,440 $275,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,540
3,540 $419,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Frontier Wealth Management LLC Portfolio

Follow Frontier Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.